Harm Reduction Group Q2 2023: First impression

Research Note

2023-08-30

09:32

Redeye states that Harm Reduction Group’s Q2 2023 report was weaker on top-line than expected. Moreover, lower personnel costs align the quarterly results with our EBITDA expectations.

Sebastian Andersson

Christian Binder

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.